Bethany Ollington

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Diabetic Retinopathy

Decision Making

Induced Apoptosis

Top Venues

International journal of molecular sciences

Tissue engineering. Part C, Methods

This page only lists publications with an associated author ORCID identifier.

Publications

Pedro R L Perdigão, Bethany Ollington, Hali Sai, Amy Leung, Almudena Sacristan-Reviriego, Jacqueline van der Spuy
Retinal Organoids from an AIPL1 CRISPR/Cas9 Knockout Cell Line Successfully Recapitulate the Molecular Features of LCA4 Disease. International journal of molecular sciences 24 (6) (2023)
Pedro R L Perdigão, Bethany Ollington, Hali Sai, Amy Leung, Almudena Sacristan-Reviriego, Jacqueline van der Spuy
Retinal Organoids from an AIPL1 CRISPR/Cas9 Knockout Cell Line Successfully Recapitulate the Molecular Features of LCA4 Disease. International journal of molecular sciences 24 (6) (2023)
Pedro R L Perdigão, Bethany Ollington, Hali Sai, Amy Leung, Almudena Sacristan-Reviriego, Jacqueline van der Spuy
Retinal Organoids from an AIPL1 CRISPR/Cas9 Knockout Cell Line Successfully Recapitulate the Molecular Features of LCA4 Disease. International journal of molecular sciences 24 (6) (2023)
Bethany Ollington, Helen Elizabeth Colley, Craig Murdoch
Immunoresponsive Tissue-Engineered Oral Mucosal Equivalents Containing Macrophages. Tissue engineering. Part C, Methods 27 (8) (2021)